Top 10 Pharma Companies in South Korea in 2021 by R&D Expenditure
Chong Kun Dang Pharmaceutical Corporation, GC Biopharma Corp, Hanmi Pharmaceuticals Co Ltd, Daewoong Co Ltd, and Celltrion Inc are the top 5 pharma companies in South Korea in 2021 by R&D Expenditure. Cumulatively, the top 10 pharma companies in South Korea reported a total R&D expenditure of $982 million, where the highest R&D expenditure was reported by Chong Kun Dang Pharmaceutical Corporation ($143 million), followed by GC Biopharma Corp ($127.64 million) and Hanmi Pharmaceuticals Co Ltd ($127.63 million), while the lowest R&D expenditure was reported by Huons Global Co Ltd ($40 million). Chong Kun Dang Pharmaceutical Corporation is of the leading pharma companies in South Korea in 2021 by R&D expenditure. The company reported revenues of $1,153 million for the fiscal year ended December 2022 (FY2022), a decrease of 1.78% over FY2021. The company manufactures, distributes, imports, and exports prescription drugs, OTC drugs, health supplements, and consumer health products. It works following therapeutic areas such as oncology, neurology and immunology, and others. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colors; aerosols; mat vaporizers and mosquito coils; and others. The company employs 1,904 people. Hanmi Pharmaceuticals Co Ltd is one of the leading pharma companies in South Korea in 2021 by R&D expenditure. The company reported revenues of $1,031 million for the fiscal year ended December 2022 (FY2022), a decrease of 1.99% over FY2021. It develops prescription drugs and over-the-counter (OTC) drugs. The company’s prescription drugs include antibiotics, antidiarrheal, osteoporosis, liver supplements, and antiemetics. Hanmi Pharmaceuticals reports its operations in three segments: Hanmi Pharm, Beijing Hanmi, and Hanmi Fine Chem. The company operates three manufacturing plants in Korea. It has a global presence in Japan, China, and Europe, and employed 2,095 people.